Research letterEffectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia
References (4)
Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the five C's of oral therapy
Dermatol Ther
(2018)Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone
Int J Dermatol
(2018)
There are more references available in the full text version of this article.
Cited by (67)
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics
2023, Journal of the American Academy of DermatologyCitation Excerpt :A multicenter retrospective study (n = 1404 cisgender men and women) demonstrated that LDOM has a good safety profile.23 Side effects include dizziness and postural hypotension (Table II).17-19,21,23,24-27,32-35,38,39,42,46,48,50-52 Hypertrichosis is most common, especially at 5 mg daily, but generally mild and may be less concerning in transmasculine patients, depending on desired gender expression.18,21,23,51
Funding sources: None.
Conflicts of interest: None disclosed.
© 2019 by the American Academy of Dermatology, Inc.